Patrick M. Caldwell, Principal Financial Officer at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 6,000 shares at $58.80 ($353K) on 2019-06-03, disclosed to the SEC on 2019-06-05.
Open-market sale of $353k BSTC by Principal Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.